DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
$ 15.95
arrow_downward
-1.24%(-0.20) 1D
10-р сарын 9, 16:00:00 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DSKYF...
Open
$ 16.88
High
$ 16.88
Low
$ 15.95
Mkt. cap
30.95 тэрбум
Avg. vol.
2.62 мян
Volume
3.41 мян
52-wk high
$ 29.10
52-wk low
$ 13.85
Beta
-1.13
Shares outstanding
1.86 тэрбум
No. of employees
20 мян
Open
$ 16.88
High
$ 16.88
Low
$ 15.95
Mkt. cap
30.95 тэрбум
Avg. vol.
2.62 мян
Volume
3.41 мян
52-wk high
$ 29.10
52-wk low
$ 13.85
Beta
-1.13
Shares outstanding
1.86 тэрбум
No. of employees
20 мян
News stories
From web sources and news partners
AD HOC NEWS
·
2 өдрийн өмнө
Daiichi Sankyo stock gets Citi Buy rating with JPY 4,700 target
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees20.2 мян
Founded2005 оны 9-р сарын 28
HeadquartersChuo City, Токио, Япон
Sector-
Websitedaiichisankyo.co.jp